Skip to main content
. 2019 Jan 22;24(3):378. doi: 10.3390/molecules24030378

Figure 2.

Figure 2

A typical workflow for virtual high-throughput screening and de novo drug design. (A) The virtual screening procedure used to select active compounds from a large library of existing molecules. SAR, structure-activity relationship. (B) The procedure for de novo design of ligands via the fragment-based approach using programs such as LUDI or SPROUT.